SMTL ID : 6x3o.2 (1 other biounit)

Co-structure of BTK kinase domain with L-005191930 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x ULY: 4-{8-amino-3-[(6R,8aS)-3-oxo-3,5,6,7,8,8a-hexahydroindolizin-6-yl]imidazo[1,5-a]pyrazin-1-yl}-3-methoxy-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide(Non-covalent)

ULY.1: 25 residues within 4Å: Chain A: L.20, G.21, T.22, G.23, V.28, A.40, I.41, K.42, F.54, A.58, M.61, L.72, I.84, T.86, E.87, Y.88, M.89, G.92, C.93, N.96, L.140, S.150, D.151, F.152, L.154 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.28, A:T.86, A:L.140, A:L.154, A:L.154 Hydrogen bonds: A:E.87, A:M.89, A:C.93, A:S.150, A:D.151 Water bridges: A:N.96 pi-Cation interactions: A:K.42

1 x 5WE: 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino)butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide(Non-covalent)

5WE.2: 7 residues within 4Å: Chain A: S.6, W.33, Y.37, V.39, M.62, S.65, Y.73 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:W.33, A:Y.37, A:V.39, A:Y.73, A:Y.73, A:Y.73 Hydrogen bonds: A:S.65 Water bridges: A:S.6

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, J. et al., Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes. Bioorg.Med.Chem.Lett. (2020)

Release Date

2020-07-22

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence